Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cognition Therapeutics, Inc. (CGTX) had Return on Tangible Equity of -9.75% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.34M |
|
-- |
|
-- |
|
$13.67M |
|
$-13.67M |
|
$10.32M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-3.34M |
|
$-13.67M |
|
$-13.61M |
|
72.77M |
|
72.77M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$47.99M |
|
$0.09M |
|
$0.40M |
|
$48.39M |
|
$13.92M |
|
-- |
|
$0.20M |
|
$14.12M |
|
$34.27M |
|
$34.27M |
|
$34.27M |
|
88.90M |
|
| Cash Flow Statement Financials | |
$-24.59M |
|
$0.01M |
|
$36.57M |
|
$25.01M |
|
$37.00M |
|
$11.99M |
|
$2.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.75% |
|
|
Return on Tangible Equity |
-9.75% |
-6.91% |
|
-9.75% |
|
$0.39 |
|
$-0.34 |
|
$-0.34 |
|